Ambys Medicines, a company focusing on regenerative medicines for serious diseases, recently launched a Series A financing round raising $60 million. The financing was led by Third Rock Ventures, which invested $40 million, while Japan’s Takeda put in $20 million.
Author Archives: Mavis Nowles
A Massachusetts start-up specializing in cell therapy has raised $72 million in an oversubscribed Series C funding round, an indication of investors’ growing interest in cell therapy treatments according to Healthcare Weekly. In its last round of funding in 2016,